Skip to content
Screener

Sight Sciences, Inc. SGHT Q3 2025 earnings

Reported November 6, 2025 · After market close

Revenue$19.9MMiss by $447.5K
EPS-$0.16Beat by $0.10
Revenue estimate$20.4M
EPS estimate-$0.26

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$23.6M
EPS estimate-$0.13

Financials

Q3 2025

Income statement

See full
Revenue$19.9M-1.2%
Gross profit$17.2M+1.7%
Operating income-$7.9M+29.6%
Net income-$8.2M+26.2%
EPS (diluted)-$0.16+27.3%

Balance sheet

See full
Cash & equivalents$92.4M-22.1%
Total debt$40.7M+15.3%
Total equity$64.3M-32.3%
Total assets$116.3M-19.0%

Cash flow

See full
Operating cash flow-$8.7M—
CapEx$170.0K+233%
Free cash flow-$8.9M—

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$180.14M-42.7%
Enterprise value$128.46M-44.4%
P/S2.4×-1.6×

Profitability

See full
Gross margin86%+0.9pp
Operating margin-59.6%-2.6pp
Net margin-60.6%-2.5pp
FCF margin-41.9%+15.6pp

Returns & leverage

See full
Return on equity-57.9%+22.2pp
Debt / equity0.6×+0.3×
Current ratio9.6×-0.6×

Segments

By segment

See full
Surgical Glaucoma$19.7M+5.8%
Dry Eye$188.0K-87.7%

FAQ

When did Sight Sciences, Inc. report Q3 2025 earnings?
Sight Sciences, Inc. (SGHT) reported Q3 2025 earnings on November 6, 2025 after market close.
What were Sight Sciences, Inc.'s Q3 2025 revenue and EPS?
Sight Sciences, Inc. reported revenue of $19.9M and eps of $-0.16 for Q3 2025.
Did Sight Sciences, Inc. beat estimates in Q3 2025?
Revenue missed the consensus estimate of $20.4M by $447.5K. EPS beat the consensus estimate of $-0.26 by $0.10.
How did Sight Sciences, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 1.2% from $20.2M a year earlier and eps grew 27.3% from $-0.22.
Where can I find Sight Sciences, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-269525) and the 10-Q periodic report (0001193125-25-269613) directly on SEC EDGAR. The filing index links above go to sec.gov.